Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | arachidonate 5-lipoxygenase | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma japonicum | IPR001024,Lipoxygenase, LH2;IPR013819,Lipoxygenase, C-terminal,domain-containing | Get druggable targets OG5_127482 | All targets in OG5_127482 |
Schistosoma mansoni | lipoxygenase | Get druggable targets OG5_127482 | All targets in OG5_127482 |
Schistosoma mansoni | lipoxygenase | Get druggable targets OG5_127482 | All targets in OG5_127482 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | Get druggable targets OG5_127482 | All targets in OG5_127482 |
Schistosoma japonicum | ko:K00461 arachidonate 5-lipoxygenase [EC1.13.11.34], putative | Get druggable targets OG5_127482 | All targets in OG5_127482 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | Get druggable targets OG5_127482 | All targets in OG5_127482 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | hypothetical protein | 0.0024 | 0.0702 | 0.4289 |
Schistosoma mansoni | loxhd1 | 0.0024 | 0.0702 | 0.0702 |
Schistosoma mansoni | lipoxygenase | 0.01 | 0.5059 | 0.5059 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.0024 | 0.0702 | 0.0702 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0074 | 0.3594 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0702 | 0.4289 |
Echinococcus multilocularis | RUN | 0.0024 | 0.0702 | 0.0702 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0702 | 0.4289 |
Echinococcus granulosus | Polycystic kidney disease protein | 0.0024 | 0.0702 | 0.0702 |
Loa Loa (eye worm) | doublecortin family protein | 0.0024 | 0.0702 | 0.4289 |
Schistosoma mansoni | hypothetical protein | 0.0185 | 1 | 1 |
Trypanosoma brucei | membrane transporter protein, putative | 0.0074 | 0.3594 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0074 | 0.3594 | 0.5 |
Onchocerca volvulus | 0.0024 | 0.0702 | 0.5 | |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.0024 | 0.0702 | 0.0702 |
Schistosoma mansoni | polycystin 1-related | 0.0024 | 0.0702 | 0.0702 |
Schistosoma mansoni | rab6-interacting | 0.0024 | 0.0702 | 0.0702 |
Schistosoma mansoni | rab6-interacting | 0.0024 | 0.0702 | 0.0702 |
Trypanosoma cruzi | membrane transporter protein, putative | 0.0074 | 0.3594 | 0.5 |
Brugia malayi | Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog | 0.004 | 0.1636 | 1 |
Loa Loa (eye worm) | voltage and ligand gated potassium channel | 0.004 | 0.1636 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0074 | 0.3594 | 0.5 |
Echinococcus multilocularis | Multi antimicrobial extrusion protein MatE | 0.0068 | 0.3221 | 0.3221 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0037 | 0.1485 | 0.5 |
Trypanosoma brucei | membrane transporter protein, putative | 0.0074 | 0.3594 | 0.5 |
Schistosoma mansoni | lipoxygenase | 0.0142 | 0.7523 | 0.7523 |
Plasmodium vivax | multidomain scavenger receptor, putative | 0.0024 | 0.0702 | 0.5 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0037 | 0.1485 | 0.5 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0142 | 0.7523 | 0.7523 |
Leishmania major | hypothetical protein, conserved | 0.0074 | 0.3594 | 0.5 |
Plasmodium falciparum | LCCL domain-containing protein | 0.0024 | 0.0702 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.1332 | 0.8141 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0074 | 0.3594 | 0.5 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.004 | 0.1636 | 0.1636 |
Echinococcus multilocularis | Polycystic kidney disease protein | 0.0024 | 0.0702 | 0.0702 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0044 | 0.1848 | 0.1848 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0074 | 0.3594 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0185 | 1 | 1 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.0024 | 0.0702 | 0.0702 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0074 | 0.3594 | 0.5 |
Echinococcus multilocularis | multidrug and toxin extrusion protein 2 | 0.0074 | 0.3594 | 0.3594 |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.0024 | 0.0702 | 0.0702 |
Brugia malayi | Doublecortin family protein | 0.0024 | 0.0702 | 0.4289 |
Onchocerca volvulus | 0.0024 | 0.0702 | 0.5 | |
Trypanosoma brucei | membrane transporter protein, putative | 0.0074 | 0.3594 | 0.5 |
Echinococcus granulosus | multidrug and toxin extrusion protein 2 | 0.0074 | 0.3594 | 0.3594 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0142 | 0.7523 | 0.7523 |
Echinococcus multilocularis | geminin | 0.0185 | 1 | 1 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0044 | 0.1848 | 0.1848 |
Echinococcus granulosus | RUN | 0.0024 | 0.0702 | 0.0702 |
Brugia malayi | hypothetical protein | 0.0024 | 0.0702 | 0.4289 |
Schistosoma mansoni | multidrug resistance protein | 0.0074 | 0.3594 | 0.3594 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.004 | 0.1636 | 0.1636 |
Trypanosoma brucei | MATE efflux family protein, putative | 0.0074 | 0.3594 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0024 | 0.0702 | 0.0702 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 8.2 uM | Inhibitory activity against 5-lipoxygenase. | ChEMBL. | No reference |
IC50 (binding) | = 8.2 uM | Inhibitory activity against 5-lipoxygenase. | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.